Major block deals totaling Rs 2,334 crore were executed on the National Stock Exchange (NSE) on Tuesday, involving significant stakes in Billionbrains Garage Ventures Ltd (Groww), Alkem Laboratories Ltd, and Gallantt Ispat Ltd. These large-volume transactions often lead to shifts in stock performance and investor sentiment.
Groww Sees Rs 1,905 Crore Transaction
Data from the NSE indicated that 8.7 crore shares of Groww changed hands at Rs 219 apiece, amassing a total value of Rs 1,905.30 crore. This transaction price represented a 2.63 percent discount compared to Monday's closing price of Rs 224.92 per share. The shares involved in this block deal constituted approximately 1.4 percent of Groww's total equity.
Groww recently reported robust Q2 revenue growth, primarily driven by increased product adoption among its user base. The company's brokerage division is actively expanding its market share across various segments, with newer offerings like Margin Trading Facility (MTF) and commodities aggressively fueling further expansion. Analysts project a 20 percent growth in the broking segment's overall order volumes over FY27-28, bolstered by market share gains and improved revenue per order.
Alkem Laboratories and Gallantt Ispat Also Impacted
In parallel, Alkem Laboratories witnessed the exchange of 5.98 lakh shares at Rs 5,050 apiece, totaling Rs 301.90 crore. The block deals also included shares of Gallantt Ispat Ltd, contributing to the combined Rs 2,334 crore figure.
For Alkem Laboratories, recent reports noted that branded formulations experienced 12.1 percent growth in Q2, particularly in chronic therapies. However, its trade generics segment remained subdued due to competitive pressures and tighter credit conditions. The company's US growth faced challenges, with a 10 percent volume increase largely offset by a 16 percent price erosion in a single product, highlighting ongoing pricing vulnerabilities.
Market Reaction and Outlook
Such substantial block deals can signal shifts in ownership or institutional rebalancing, often leading to short-term volatility in the affected stocks. Investors will be closely watching how these companies integrate the new shareholdings and whether the underlying business fundamentals continue to support their growth trajectories. The insights into Groww's operational efficiency and Alkem Labs' market performance provide a backdrop against which these large-scale transactions are being interpreted by the market.